GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

This study will confirm device efficacy and safety in the clinical setting after the launch of the GORE® VIABAHN® Endoprosthesis for the treatment of symptomatic peripheral arterial disease in the superficial femoral arteries.

Inclusion Criteria:

• Symptomatic peripheral arterial disease in superficial femoral artery lesions